Establishing and Characterizing NPC Cell Lines
Corresponding Organization : Hong Kong Baptist University
Other organizations : Hong Kong University of Science and Technology, University of Hong Kong, Bioscience (China), Chinese University of Hong Kong
Variable analysis
- PDGF-BB treatment
- KX2-391 treatment
- Bosutinib treatment
- Saracatinib treatment
- Cell growth/proliferation
- Phenotypic changes
- Cell lines used (HONE1, HK1, CNE1, CNE2, SUNE1, C666-1, NPC43, NP69, NP460, HK11.19)
- Cell culture conditions (as previously described in references [4] and [18])
- Concentration of small molecule inhibitors (10 mM stock solutions in DMSO)
- Formulation of KX2-391 for in vivo assay (4% DMSO, 30% PEG-300, 66% PBS)
- None specified
- DMSO vehicle control for small molecule inhibitor treatments
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!